NCT05323370
- Conditions
- Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +24 more
- Locations
-
- University hospital Tours, France
Clinical trial condition
Perivascular Epithelioid Cell Neoplasms
Explore clinical trials studying Perivascular Epithelioid Cell Neoplasms. Study availability and eligibility vary by location and protocol.
48 public trials
10 recruiting studies
Perivascular Epithelioid Cell Neoplasms trial results
NCT03253913
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- University of Cincinnati Cincinnati, Ohio, United States
NCT03062943
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Pneumology unit Milan, Italy
NCT02325505
- Conditions
- Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +25 more
- Locations
-
- InCor Heart Institute São Paulo, Brazil
- InCor Heart Institute, Research Center São Paulo, Brazil
- InCor Heart Institute São Paulo, Brazil
Completed
RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS
NCT00126672
- Conditions
- Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
- Locations
-
- Loma Linda University School of Medicine Loma Linda, California, United States
- Connecticut Children's Medical Center Hartford, Connecticut, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- New York University Medical Center New York, United States
NCT02484664
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
NCT03525834
- Conditions
- Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
- Locations
-
- Novartis Investigative Site Wuhan, Hubei, China
- Novartis Investigative Site Shanghai, Shanghai Municipality, China
- Novartis Investigative Site Chengdu, Sichuan, China
- Novartis Investigative Site Beijing, China
Completed
Glutamine PET Imaging in LAM
NCT04388371
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States
NCT00366509
- Conditions
- Asthma, Bronchial Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +28 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01059318
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Center for LAM Research and Clinical Care Boston, Massachusetts, United States
- University of Cincinnati, Department of Internal Medicine, Pulmonary, Critical Care & Sleep Medicine, Cincinnati, Ohio, United States
- Novartis Investigative Site Lyon, France
- Novartis Investigative Site Milan, Italy